Good numbers ..will not spoil it but just to highlight..
1. Even on Japan, numbers of 350 000 prescriptions per year @ Gross usd 750 and Net Usd 540
2. Net sales Usd 540 >>190mln usd
3. Sales Multiplier is 15x >> usd 2.9bln or SP usd 2 per share
4. Not accnted for US population 2.5x , not accounted for automatic refills at least 3x , and AI driven platform to capture 6.3mln TAM can be another 2x
5. Japan still growing 40% YoY
did I get to usd 8 per share or not?
Ann: Final Sofdra Labelling Discussions with FDA, page-110
-
- There are more pages in this discussion • 173 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |